Aktienanalyse zu QT Imaging Holdings Inc (QTI)QTIQT Imaging Holdings Inc

QT Imaging Holdings, Inc. is a medical device company engaged in the research, development, and commercialization of body imaging systems using low-frequency sound waves. The Company's products include QTI Breast Acoustic CT Scanner and QTviewer Software. QTI’s Breast Acoustic CT scanner with QTViewer viewer software is the only three-dimensional (3D) imaging device to receive United States Food and Drug Administration (FDA) clearance for use as a transmission and reflection ultrasonic imaging system of a patients breast. QTviewer is its proprietary image viewing and analysis platform, purpose-built to interpret the rich, quantitative datasets generated by the QTI Breast Acoustic CT™ scanner. The QTviewer allows users to rotate, zoom, and cross-navigate entire breast volumes. Whether isolating lesions or exploring architectural distortion, radiologists can interact with the data dynamically to gain an understanding of tissue structure and lesion morphology. It operates in the Healthcare sector (ELECTROMEDICAL AND ELECTROTHERAPEUTIC APPARATUS industry).

QT Imaging Holdings Inc appears to be a good buy right now due to its recent 103% revenue growth in Q2 2026, bringing total revenue to $7.4 million, and a current price of $3.09, which is below its historical SMA of $4.982. The company also received FDA approval for enhanced product capabilities, which could drive future sales. However, the main risk is the high debt-to-equity ratio of 680.85%, indicating potential financial instability.